Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
46,69 USD | -0,28% | +0,09% | -2,36% |
Omzet 2024 * | 515 mln. 477 mln. | Omzet 2025 * | 633 mln. 587 mln. | Marktkapitalisatie | 3,84 mld. 3,56 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -532 mln. -493 mln. | Nettowinst (verlies) 2025 * | -453 mln. -420 mln. | EV/omzet 2024 * | 6,82 x |
Nettoliquiditeiten 2024 * | 334 mln. 310 mln. | Nettoliquiditeiten 2025 * | 298 mln. 277 mln. | EV/omzet 2025 * | 5,6 x |
K/w-verhouding 2024 * |
-7,24
x | K/w-verhouding 2025 * |
-9,06
x | Werknemers | 1.276 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,88% |
Recentste transcriptie over Ultragenyx Pharmaceutical Inc.
1 dag | -0,28% | ||
1 week | +0,09% | ||
Lopende maand | -9,73% | ||
1 maand | -11,49% | ||
3 maanden | -3,27% | ||
6 maanden | +32,76% | ||
Lopend jaar | -2,36% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Emil Kakkis
FOU | Founder | 63 | 22-04-10 |
Howard Horn
DFI | Director of Finance/CFO | 47 | 16-10-23 |
Eric Crombez
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Deborah Dunsire
BRD | Director/Board Member | 61 | 06-04-17 |
Emil Kakkis
FOU | Founder | 63 | 22-04-10 |
Daniel Welch
CHM | Chairman | 66 | 08-04-15 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
2.21% | 1 M€ | -.--% | - | |
0.82% | 4 M€ | +20,15% | ||
0.43% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 46,69 | -0,28% | 543 698 |
27-03-24 | 46,82 | +2,99% | 551 352 |
26-03-24 | 45,46 | +0,09% | 362 335 |
25-03-24 | 45,42 | -0,94% | 442 715 |
22-03-24 | 45,85 | -1,71% | 403 665 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,36% | 3,84 mld. | |
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |